Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Deciphera
Marketing
Deciphera cracks the door open for off-label cancer drug use
Without a phase 3 trial win, Deciphera is counting on a safety edge to potentially drive off-label use in GIST.
Angus Liu
Jan 25, 2022 12:02pm
Deciphera reduces workforce by 35%, cuts development of 2 drugs
Nov 30, 2021 2:00pm
Deciphera misses blockbuster opportunity with Qinlock flop
Nov 5, 2021 11:43am
The top 20 most expensive pharmacy drugs in the U.S. in 2021
Mar 9, 2021 12:12pm
Deciphera reworks Qinlock pandemic launch, preps pipeline
Feb 19, 2021 10:21am
Deciphera wins early FDA nod for Qinlock in rare stomach cancer
May 18, 2020 12:05pm
